HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

human atrial natriuretic factor prohormone (1-30)

the 30-amino acid fragment at the N-terminal of the human ANF prohormone, ATRIAL NATRIURETIC FACTOR (1-126); a long-acting natriuretic peptide (LANP); found in humans; do not confuse with LANP protein
Also Known As:
atrial natriuretic factor prohormone (1-30), human; ANF precursor (1-30); LANP peptide; atrial natriuretic factor (1-30), human; atrial natriuretic factor precursor (1-30); atrial natriuretic factor prohormone (1-30); atriopeptin prohormone (1-30); long-acting natriuretic peptide; pro-ANF (1-30)
Networked: 37 relevant articles (2 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Vesely, David L: 21 articles (04/2014 - 05/2002)
2. Vesely, D L: 10 articles (03/2010 - 03/2001)
3. Gower, W R: 7 articles (08/2008 - 11/2003)
4. Gower, William R: 7 articles (11/2007 - 01/2005)
5. Eichelbaum, Ehrentraud J: 6 articles (06/2009 - 11/2006)
6. Sun, Ying: 6 articles (06/2009 - 11/2006)
7. Vesely, Brian A: 6 articles (11/2007 - 01/2005)
8. Vesely, B A: 5 articles (11/2006 - 11/2003)
9. Skelton, William P: 4 articles (06/2013 - 06/2009)
10. Alli, A A: 4 articles (08/2008 - 06/2005)

Related Diseases

1. Carcinoma (Carcinomatosis)
03/01/2010 - "Long-acting natriuretic peptide, although it did not eliminate any of the human squamous cell lung carcinomas did decrease the volume of one carcinoma to only 2% (P < 0.0001) of the untreated carcinomas. "
03/01/2010 - "long-acting natriuretic peptide, decreased the volume of one squamous cell lung carcinoma to 2% of that of untreated animals, suggesting that it, too, has beneficial effects on squamous cell lung cancers."
03/01/2010 - "The squamous cell lung carcinomas that were not eliminated, with the exception of the one LANP-treated tumour that decreased to only 2% of the volume of the untreated cancers, grew rapidly but their growth velocity compared to controls decreased by 76%, 40%, 38% and 25% in the vessel dilator, atrial natriuretic peptide, kaliuretic peptide and long-acting natriuretic peptide groups respectively (P < 0.05). "
01/01/2010 - "atrial natriuretic peptide, vessel dilator, kaliuretic peptide and long-acting natriuretic peptide (LANP) which decrease up to 97% of human pancreatic, breast, colon, prostate, kidney and ovarian carcinomas as well as small-cell and squamous cell lung cancer cells within 24 hours in cell culture. "
01/01/2011 - "The heart is a sophisticated endocrine gland synthesizing the atrial natriuretic peptide prohormone which contains four peptide hormones, i.e., atrial natriuretic peptide, vessel dilator, kaliuretic peptide and long-acting natriuretic peptide, which decrease up to 97% of human pancreatic, breast, colon, prostate, kidney and ovarian carcinomas as well as small-cell and squamous cell lung cancer cells in cell culture. "
2. Neoplasms (Cancer)
3. Small Cell Lung Carcinoma (Small Cell Lung Cancer)
4. Adenocarcinoma
5. Lung Neoplasms (Lung Cancer)
03/01/2010 - "long-acting natriuretic peptide, decreased the volume of one squamous cell lung carcinoma to 2% of that of untreated animals, suggesting that it, too, has beneficial effects on squamous cell lung cancers."
01/01/2010 - "atrial natriuretic peptide, vessel dilator, kaliuretic peptide and long-acting natriuretic peptide (LANP) which decrease up to 97% of human pancreatic, breast, colon, prostate, kidney and ovarian carcinomas as well as small-cell and squamous cell lung cancer cells within 24 hours in cell culture. "
02/28/2006 - "vessel dilator, long acting natriuretic peptide, kaliuretic peptide, and atrial natriuretic peptide and their intracellular mediator cyclic GMP decreased the number of human squamous lung cancer cells 51, 22, 25, 21, and 30%, respectively. "
01/01/2011 - "The heart is a sophisticated endocrine gland synthesizing the atrial natriuretic peptide prohormone which contains four peptide hormones, i.e., atrial natriuretic peptide, vessel dilator, kaliuretic peptide and long-acting natriuretic peptide, which decrease up to 97% of human pancreatic, breast, colon, prostate, kidney and ovarian carcinomas as well as small-cell and squamous cell lung cancer cells in cell culture. "
01/01/2009 - "Four cardiovascular hormones, ie, vessel dilator, long-acting natriuretic peptide, kaliuretic peptide, and atrial natriuretic peptide each at 1 mmol/L, decrease up to 97% of human breast, ovarian, pancreatic, colon, kidney, and prostate adenocarcinoma cells, as well as small cell and squamous cell lung cancer cells within 24 hours. "

Related Drugs and Biologics

1. atrial natriuretic factor prohormone (31-67)
2. atrial natriuretic factor precursor (79-98)
3. Hormones
4. atrial natriuretic factor prohormone (95-126) (Ularitide)
5. Atrial Natriuretic Factor (ANF)
6. Peptide Hormones (Polypeptide Hormones)
7. Cyclic GMP
8. Brain Natriuretic Peptide (Natrecor)
9. Peptides
10. DNA (Deoxyribonucleic Acid)